C4 THERAPEUTICS INC (CCCC) Stock Cash Flow
NASDAQ:CCCC - US12529R1077 - Common Stock
2.64 USD
-0.04 (-1.49%)
2.64 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -111.58M | -105.32M | -132.49M | -128.18M | -83.89M | |||
| Depreciation Amortization | 1.99M | 1.82M | 1.88M | 1.68M | 1.49M | |||
| Change In Working Capital | -8.15M | 7.65M | -6.94M | -16.78M | -30.09M | |||
| Interest Paid | N/A | 0.00 | 990.00K | 1.62M | 1.31M | |||
| Taxes Paid | N/A | 0.00 | 1.00M | N/A | 0.00 | |||
| Other non cash items | 30.33M | 30.69M | 30.71M | 37.34M | 25.53M | |||
| OPERATING CASH FLOW | -87.41M | -65.16M | -106.84M | -105.94M | -86.97M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -180.00K | -1.71M | -5.50M | -1.28M | |||
| Other Investing Activity | 82.05M | -51.09M | 160.06M | 63.92M | -188.06M | |||
| INVESTING CASH FLOW | 81.88M | -51.27M | 158.35M | 58.42M | -189.34M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -12.50M | N/A | 0.00 | |||
| Stock Issued/Repurchased | 10.16M | 44.95M | 57.62M | 780.00K | 2.04M | |||
| Other Financing Activity | 407.00K | 382.00K | 368.00K | 370.00K | 169.36M | |||
| FINANCING CASH FLOW | 10.57M | 45.34M | 45.49M | 1.15M | 171.40M | |||
| CHANGE IN CASH | 5.04M | -71.09M | 97.00M | -46.37M | -104.91M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -87.41M | -65.16M | -106.84M | -105.94M | -86.97M | |||
| Capital Expenditure | N/A | -180.00K | -1.71M | -5.50M | -1.28M | |||
| FREE CASH FLOW | -87.58M | -65.34M | -108.55M | -111.44M | -88.25M | |||
All data in USD